fbpx
Menu

Synthetic Biologics Reports Third Quarter 2018 Operational Highlights and Financial Results

Share

– Announced Agreement with Cedars-Sinai Medical Center to Co-fund a Phase 2b Investigator

– Sponsored Clinical Study of SYN-010, for the Treatment of IBS-C

– Strengthened Balance Sheet in Support of Microbiome-Focused Clinical Development Programs…

[Read on via official release]

Source: US SEC
View full document:
EX-991_of_8-K_for_Synthetic_Biologics_Inc__8-K-11-08-2018